Can digital subscriptions serve as a fresh source of income for ISRG in 2026?

Intuitive Surgical Eyes Digital Subscription Revenue in 2026

Intuitive Surgical is preparing to shift its My Intuitive+ (MIA+) platform from a complimentary feature to a paid subscription service, with significant revenue implications expected by 2026. Launched alongside the da Vinci 5 system, MIA+ brings together Telepresence, simulation tools, and case analytics to support surgeons in their practice and foster collaboration.

Initially, customers who purchased the da Vinci 5 received a year of free access to MIA+. However, after a major software upgrade planned for 2025, this complimentary period was extended, resulting in some revenue being deferred from system sales to service income. By mid-2026, users will need to decide whether to renew their subscriptions and pay for ongoing access. The uptake and pricing of renewals will largely depend on the value users see in features like case insights and Telepresence.

This move signals a broader transition for Intuitive Surgical from hardware-based sales to digital service monetization. Currently, the company already generates 81% of its income from recurring sources, but MIA+ introduces a new software-driven revenue stream that is linked to digital engagement rather than just procedure volume. Management has also pointed out that integrating case insights with Force Feedback technology could further enhance the platform’s value, especially as Force instruments become more widely available, potentially boosting renewal rates.

Financially, even moderate adoption and renewal rates among the growing da Vinci 5 user base could create a profitable service revenue stream. If digital subscriptions gain traction, Intuitive Surgical could see accelerated growth in service income from 2026 onward, further diversifying its business beyond equipment and instrument sales.

Industry Peers Expand Digital Service Offerings

Other companies in the robotic surgery space, such as Globus Medical and Stereotaxis, are also investing in digital platforms linked to their surgical systems, aiming to generate additional high-margin revenue.

Globus Medical is leveraging its digital ecosystem to drive recurring income around its ExcelsiusGPS robotic platform. During its recent earnings call, the company highlighted the integration of imaging, navigation, and robotics into a seamless system—EGPS, EHUB, and E3D—ensuring consistent workflows and data across operating rooms.

With over 120,000 procedures performed using ExcelsiusGPS, Globus Medical’s installed base is well-positioned for revenue from software, services, and upgrades. The company’s flexible leasing options are expected to accelerate system placements, while increased adoption of digital workflows and navigation software updates should support a subscription-based revenue model in the coming years.

Stereotaxis is developing a clear digital subscription approach with its GenesisX system and the Synchrony/SynX platform. The company’s business model pairs robotic system sales with recurring, high-margin catheter revenue. The Synchrony and SynX platforms add remote connectivity, workflow enhancements, and AI-powered features, which are expected to evolve into a software-as-a-service income stream. Stereotaxis anticipates that growing adoption of its systems and catheters could push recurring revenue beyond $10 million per quarter by 2026, setting the stage for a shift toward subscription-based, higher-margin income streams in the future.

The Next Phase of AI Investment

While artificial intelligence has already created significant wealth, the most well-known AI stocks may not offer the largest gains going forward. Lesser-known companies addressing major global challenges with AI could present more lucrative opportunities in the near future.